Mizuho Maintains Outperform on Chemours, Lowers Price Target to $18
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $20 to $18.
Mizuho analyst John Roberts maintains Chemours (NYSE:CC) with a Outperform and lowers the price target from $20 to $18.